Amber C. King

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML

Maximilian Stahl, Kamal Menghrajani, Andriy Derkach et al. · Blood Advances · 2021 · 188 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia

Amber C. King, Jeremy J. Pappacena, Martin S. Tallman et al. · Leukemia Research · 2019 · 64 citations · Full text

Medicine, Hematology, Oncology +13

Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant

Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2021 · 43 citations · Full text

Medicine, Hematology, Oncology +15

Safety and Efficacy of Combined Ruxolitinib and Thalidomide in Patients with Myelofibrosis: A Phase II Study

Raajit K. Rampal, Srđan Verstovšek, Sean M. Devlin et al. · Blood · 2019 · 29 citations

Medicine, Hematology, Pharmacology +10

First record of Tapesia yallundae as the teleomorph of Pseudocercosporella herpotrichoides var. acuformis, and its occurrence in the field in the Federal Republic of Germany

Amber C. King · Plant Pathology · 1990 · 28 citations

Life Sciences, Botany, Plant Sciences +10